Rhumbline Advisers Has $4.54 Million Stake in Rhythm Pharmaceuticals, Inc. $RYTM

Rhumbline Advisers grew its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 3.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 85,719 shares of the company’s stock after buying an additional 2,988 shares during the period. Rhumbline […]

Leave a Reply

Your email address will not be published.

Previous post Elevance Health, Inc. $ELV Position Raised by Modern Wealth Management LLC
Next post F3 Uranium (CVE:FUU) Stock Price Down 11.6% – Here’s What Happened